Comparative treatment planning between proton and X-ray therapy in locally advanced rectal cancer

Radiotherapy and Oncology

Volumn 41, Issue 3, 1996, Pages 263-272

  Isacsson, Ulf ^a   Montelius, Anders ^a   Jung, Bo ^a   Glimelius, Bengt ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Comparative treatment; Proton therapy; Rectal surgery; X ray therapy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAST PROTON RADIATION; FEMALE; HUMAN; MALE; MEGAVOLTAGE RADIOTHERAPY; PRIORITY JOURNAL; RECTUM CANCER; TREATMENT PLANNING;

EID: 0030465448     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(96)01851-8     Document Type: Article

References (54)

1. [1] Ahnesjö, A., Saxner, M. and Trepp, A. A pencil beam model for photon dose calculation. Med. Phys. 19: 263-273, 1992.
2. [2] Archambeau, J.O. and Shymko, R.M. Tissue population configuration as a modifier of organ dose-response. Int. J. Radiat. Oncol. Biol. Phys. 15: 727-734, 1988.
3. [3] Archambeau, J., Slater, J.D., Slater, J.M. and Tangeman, R. Role for proton beam irradiation in treatment of pediatric CNS malignancies. Int. J. Radiat. Oncol. Biol. Phys. 22: 287-294, 1992.
4. [4] Brahme, A. Dosimetric precision requirements in radiation therapy. Proceedings of Eighth International Conference on Use of Computers in Radiation Therapy, 1984, pp. 269-274.
5. [5] Brierley, J.D., Cummings, B.J., Wong, C.S. et al. Adenocarcinoma of the rectum treated by radical external radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 31: 255-259, 1995.
6. [6] Bonnett, D.E. Current developments in proton therapy: a review. Phys. Med. Biol. 38: 1371-1392, 1993.
7. [7] Burman, C., Kutcher, G.J., Emami, D. and Goitein, M. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys. 21: 123-135, 1991.
8. [8] Coutrakon, G., Hubbard, J., Johanning, J., Maudsley, G., Slaton, T. and Morton, P. A performance study of the Loma Linda proton medical accelerator. Med. Phys. 21: 1691-1701, 1994.
9. [9] Deacon, J.M., Peckham, M.J. and Steel, G.G. The radioresponsiveness of human tumours and the initial slope of the cell survivals curve. Radiother. Oncol. 4: 317-323, 1984.
10. [10] Emami, B., Lyman, J., Brown, A. et al. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 21; 109-122, 1991.
11. [11] Fertil, B. and Malaise, E.P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 7: 621-629, 1981.
12. [12] Fowler, J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 2: 679-694, 1989.
13. [13] Frykholm, G., Glimelius, B. and Påhlman, L. Preoperative irradiation with and without chemotherapy (MFL) in the treatment of primarily non-resectable adenocarcinoma of the rectum: results from two consecutive studies. Eur. J. Cancer Clin. Oncol. 25: 1535-1541, 1989.
14. [14] Frykholm, G., Glimelius, B., Richter, S. and Carlsson, J. Heterogeneity in antigenic expression and radiosensitivity in human colon carcinoma cell lines. In Vitro Cell. Dev. Biol. 27: 900-906, 1991.
15. [15] Gerard, J.P., Roy, P., Coquard, R. et al. Combined curative radiation therapy alone in (T1) T2-T3 rectal adenocarcinoma: a pilot study of 29 patients. Radiother. Oncol. 38: 131-137, 1996.
16. [16] Glimelius, B., Isacsson, U., Påhlman, L. Radiotherapy in addition to radical surgery in rectal cancer. Acta Oncol. 34: 565-570, 1995.
17. [17] Goitein, M. The probability of controlling an inhomogenously irradiated tumor. In: Evaluation of Treatment Planning for Particle Beam Radiotherapy, pp. 5.8.1-5.8.17. Editor: S. Zink. National Cancer Institute, Bethesda, 1987.
18. [18] Herbert, S.H., Solin, L.J., Hoffman, J.P. et al. Volumetric analysis of small bowel displacement from radiation portals with the use of a pelvic tissue expander. Int. J. Radiat. Oncol. Biol. Phys. 25: 885-893, 1993.
19. [19] Hindley, A. and Cole, H. Use of peritoneal insufflation to displace the small bowel during pelvic and abdominal radiotherapy in carcinoma of the cervix. Br. J. Radiol. 66: 67-73, 1993.
20. [20] ICRU Report No. 50. Prescribing, recording and reporting photon beam therapy. International Commission on Radiation Units and Measurement, Bethesda, MD, 1993.
21. [21] Jansson Frykholm, G., Isacsson, U., Nygård. K. et al. Preoperative radiotherapy in rectal carcinoma: aspects of acute adverse effects and radiation technique. Int. J. Radiat. Oncol. Biol. Phys. 35: 1039-1048, 1996.
22. [22] Koyama, S., Tsujii, H., Yokota, H. et al. Proton beam therapy for patients with esophageal carcinoma. Jpn. J. Clin. Oncol. 24: 144-153, 1994.
23. [23] Kutcher, G.J. and Burman, C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int. J. Radiat. Oncol. Biol. Phys. 16: 1623-1630, 1989.
24. [24] Knöös. T., Ceberg, C., Weber, L. and Nilsson, P. The dosimetric verification of a pencil beam based treatment planning system. Phys. Med. Biol. 39: 1609-1628, 1994.
25. [25] Källman, P., Lind, B.K. and Brahme, A. An algorithm for maximizing the probability of complication free tumor control in radiotherapy. Phys. Med. Biol. 37: 871-890, 1992.
26. [26] Lee, M., Wynne, C., Webb, S., Nahum, A.E. and Dearnaley, D. A comparison of proton and megavoltage X-ray treatment planning for prostate cancer. Radiother. Oncol. 33: 239-253, 1994.
27. [27] Levin, C. Potential for gain in the use of proton beam boost to the para-aortic lymph nodes in carcinoma of the cervix. Int. J. Radiat. Oncol. Biol. Phys. 22: 355-359, 1992.
28. [28] Lyman, J.T. complication probability as assessed from dose-volume histograms. Radiat. Res. 104: 13-19, 1985.
29. [29] Minsky, B.D., Cohen, A.M., Kemeny, N. et al. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J. Clin. Oncol. 10: 79-84, 1992.
30. [30] Miralebell, R., Crowell, C., Suit, H. Potential improvement of the three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer. Int. J. Radiat. Oncol. Biol. Phys. 22: 305-310, 1992.
31. [31] Moertel, G. Chemotherapy for rectal cancer. Cancer 330: 1136-1142, 1994.
32. [32] Montelius, A., Blomquist, E., Naeser, P. et al. The narrow proton beam therapy unit at the The Svedberg Laboratory in Uppsala. Acta Oncol. 30: 739-745, 1991
33. [33] Montelius, A., Jung, B., Rikner, G., Murman, A. and Russell, K. Quality assurance tests of the TMS-radix treatment planning system. In: Advanced Radiation Therapy Tumour Response Monitoring and Treatment Planning, pp. 523-527. Editor: A. Breit. Springer-Verlag, Berlin, 1992.
34. [34] Munzenrider, J., Austin-Seymour, M., Blitzer, P. et al. Proton therapy at Harvard. Strahlentherapie 161: 756-763, 1985.
35. [35] Munzenrider, J., Brown, A.P., Chu, J.C.H. et al. Numerical scoring of treatment plans. Int. J. Radiat. Oncol. Biol. Phys. 21: 147-163, 1991.
36. [36] Nahum, A.E. and Tait, D.M. Maximizing local control by customized dose prescription for pelvic tumours. In: Advanced Radiation Therapy Tumour Response Monitoring and Treatment Planning, pp. 425-431. Editor. A. Breit. Springer-Verlag, Berlin, 1992.
37. [37] Nowakowski, V., Castro, J., Petti, P. et al. Charged particle radiotherapy of paraspinal tumours. Int. J. Radiat. Oncol. Biol. Phys. 22: 295-303, 1992.
38. [38] Orton, C.G. and Wolg-Rosenblum, S. Dose dependence of complication rates in cervix cancer radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 12: 37-44, 1986.
39. [39] Papillon, J. New prospects in the conservative treatment of rectal cancer. Dis. Colon Rectum 27: 695-700, 1984
40. [40] Papillon, J. The future of external beam irradiation as initial treatment of rectal cancer. Br. J. Surg. 74: 449-454, 1987.
41. [41] Rich, T.A., Weiss, D.R., Lew, T., Galdibini, J.J., Chaffey, J.T. and Donaldson, G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 52: 1317-1329, 1983
42. [42] Russell, K.R., Grusell, E. and Montelius, A. Dose calculations in proton beams: range straggling and energy scaling. Phys. Med. Biol. 40: 1031-1043, 1995.
43. [43] Schultheiss, T.E., Orton, C.G. and Peck, R.A. Models in radiotherapy: volume effects. Med. Phys. 10: 410-415, 1983.
44. [44] Sischy, B., Hinson, E.J., and Wilkinson, D.R. Definitive radiation therapy for selected cancers of the rectum. Br. J. Surg. 75: 901-903, 1988.
45. [45] Slater, J.M., Slater, J.D. and Archambeau, J. Carcinoma of the tonsillar region: potential for use of proton beam therapy. Int. J. Radiat. Oncol. Biol. Phys. 22: 311-319, 1992.
46. [46] Slater, J.D., Slater, J.M. and Wahlen, S. The potential for proton beam therapy in locally advanced carcinoma of the cervix. Int. J. Radiat. Oncol. Biol. Phys. 22: 343-347, 1992.
47. [47] Smit, B. Prospects for proton therapy in carcinoma of the cervix. Int. J. Radiat. Oncol. Biol. Phys. 22: 349-353, 1992.
48. [48] Tatsuzaki, H., Urie, M. and Linggood, R. Comparative treatment planning: proton versus X-ray beams against glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 22: 265-273, 1992.
49. [49] Tatsuzaki, H., Urie, M. and Willett, C. 3-D Comparative study of protons versus X-ray radiation therapy for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 22: 369-374, 1992.
50. [50] Verhey, L.J. and Munzenrider, J.E. Proton beam therapy. Annu. Rev. Biophys. Bioeng. 11: 331-357, 1982.
51. [51] Wambersie, A., Gregroire, V. and Brucher, J.M. Potential clinical gain of proton (and heavy ion) beams for brain tumors in children. Int. J. Radiat. Oncol. Biol. Phys. 22: 275-286, 1992.
52. [52] Wassif, S.B. Ten years' experience with a multimodality treatment of advanced stages of rectal cancer. Cancer. 52: 2017-2024, 1983.
53. [53] Webb, S. and Nahum, A.E. A model for calculating tumour control probability in radiotherapy including the effect of inhomogeneous distributions of dose and clonogenic cell density. Phys. Med. Biol. 38: 653-666, 1993.
54. [54] Wolbarst, A.B. Optimization of radiation therapy III: the critical volume model. Int. J. Radiat. Oncol. Biol. Phys. 10: 741-745, 1984.